Related Experiment Videos
[Primary pulmonary hypertension in children]
Zeitschrift Fur Kardiologie
|November 1, 1982
Summary
This case report details an infant diagnosed with primary pulmonary hypertension at 12 months, showing rapid right-ventricular hypertrophy. Despite treatment, the infant succumbed to the condition, with histopathology confirming the diagnosis.
Area of Science:
- Pediatric Cardiology
- Pulmonary Hypertension Research
- Infant Cardiovascular Health
Background:
- Primary pulmonary hypertension (PPH) is a rare and severe condition affecting infants.
- Early diagnosis and intervention are critical for managing pediatric cardiovascular diseases.
- Understanding the progression of PPH in infants is crucial for developing effective treatments.
Observation:
- A 12-month-old infant, under cardiological observation since birth, presented with symptoms of primary pulmonary hypertension.
- Echocardiography revealed rapidly progressing right-ventricular hypertrophy.
- Cardiac catheterization confirmed pulmonary hypertension without congenital heart defects.
Findings:
- The infant's condition rapidly worsened, indicating aggressive disease progression.
- Standard treatments, including isoproterenol and tolazoline, proved ineffective.
- Histopathological examination post-mortem supported the diagnosis of primary pulmonary hypertension.
Implications:
- This case highlights the aggressive nature and poor prognosis of primary pulmonary hypertension in infants.
- It underscores the need for novel therapeutic strategies for pediatric pulmonary hypertension.
- Further research into the pathophysiology of PPH in neonates and infants is warranted.